Zhou Qiaoli, Jing Mao, Ren Haitao, Li Gaokai, Wang Zongjiao
Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Acupuncture and moxibustion and Trauma College of Hubei University of Traditional Chinese Medicine, Wuhan City, Hubei Province, China.
Medicine (Baltimore). 2025 Mar 21;104(12):e41458. doi: 10.1097/MD.0000000000041458.
BACKGROUND: Electroacupuncture (EA) is utilized to address various health conditions. Herein, we designed a systematic review and meta-analysis to evaluate the efficacy of EA on clinical and immunological factors in herpes zoster (HZ) based on randomized clinical trials. METHODS: Four international databases and 3 Chinese databases were searched until January 2024. We used RevMan 5.3 for meta-analysis and presented the data as standardized mean difference (SMD) or odds ratio (OR) and 95% confidence interval. RESULTS: A total of 1361 records were identified in the databases and at last, 19 articles were entered into the meta-analysis. The result shows a negative pooled SMD of -2.55 (P < .00001) for the VAS score. The pooled SMD for cessation of pustules time in the case group compared to the control group was -0.69 (P = .0008), for pain relief time was -1.36 (P = .002), for the time to scab was -0.47 (P = .009), and for time to remove scab was -1.01 (P = .0003). The pooled OR for the incidence of postherpetic neuralgia was 0.11 (P < .00001), and the total effective rate was 4.25 (P < .00001). The pooled SMD for the cluster of differentiation (CD)3 count was 2.59 (P = .07), for the CD4 count was 2.81 (P = .04), for the CD8 count was -0.75 (P = .50), and for theCD4/CD8 ratio was 1.12 (P = .15). CONCLUSIONS: The results indicate that the EA treatment had several significant benefits compared to Western medicine (WM) in HZ patients in terms of clinical and immunological factors. But, the combination of treatments of EA with WM had better effects compared to EA treatment alone.
背景:电针被用于治疗各种健康状况。在此,我们设计了一项系统评价和荟萃分析,以基于随机临床试验评估电针治疗带状疱疹(HZ)的临床和免疫因素疗效。 方法:检索了四个国际数据库和三个中文数据库直至2024年1月。我们使用RevMan 5.3进行荟萃分析,并将数据表示为标准化均数差(SMD)或比值比(OR)及95%置信区间。 结果:数据库中共识别出1361条记录,最终19篇文章纳入荟萃分析。结果显示视觉模拟评分(VAS)的合并SMD为 -2.55(P <.00001)。与对照组相比,病例组脓疱停止时间的合并SMD为 -0.69(P =.0008),疼痛缓解时间为 -1.36(P =.002),结痂时间为 -0.47(P =.009),痂皮脱落时间为 -1.01(P =.0003)。带状疱疹后神经痛发生率的合并OR为0.11(P <.00001),总有效率为4.25(P <.00001)。分化簇(CD)3计数的合并SMD为2.59(P =.07),CD4计数为2.81(P =.04),CD8计数为 -0.75(P =.50),CD4/CD8比值为1.12(P =.15)。 结论:结果表明,在临床和免疫因素方面,与西药相比,电针治疗对HZ患者有多项显著益处。但是,电针与西药联合治疗比单独电针治疗效果更好。
Evid Based Complement Alternat Med. 2022-7-4
Cochrane Database Syst Rev. 2022-2-1
Medicine (Baltimore). 2020-11-6
Cochrane Database Syst Rev. 2023-12-5
Altern Ther Health Med. 2010
Clin Cosmet Investig Dermatol. 2023-11-2
Evid Based Complement Alternat Med. 2022-7-4